Accessing the inaccessible
Reimagining Small Molecule Therapeutics through AI
Pushing the boundaries of what is possible with small molecule therapeutics
Targeting inaccessible targets in the brain and inside the cell.
Bringing the specificity of biologics to small molecule drug design.
Unlocking novel chemical space through AI-enabled drug discovery.
Developing life changing medicines for cancer and neurological disease
Explore our rapidly growing pipeline.
Meet our world-class team
We are a spin-out based on ground-breaking research
from the University of Cambridge, UK
News & Updates
Read up on the latest news, updates and announcements from the PharmEnable team.